Clinical Trial Update: P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for P1101 and Anti-PD1 in patients after curative surgery for hepatitis B-related hepatocellular carcinoma, spanning Phase 1 and Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Anti-PD1
• P1101

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN